Affinity exploration of a bispecific ADAPT towards CD22 for therapeutic purposes
Leukemia is the most common type of cancer in children, with B-cell acute lymphocytic leukemia (B-ALL) being a common type in both children and adults. Different types of treatments are available, such as chemotherapy, stem cell treatment and immunotherapy. However, a recurring problem is relapses, with the survival rate after relapse being very low. In combating this issue new methods have been d